NFKB1 and chronic obstructive pulmonary disease: Treatment of CS-induced COPD mouse model with ILG showed a decrease in inflammatory cytokine levels in BAL fluid and NF-κB in the lungs, as well as an increase in Nrf2 and HO-1, compared with the control group [70].